Pfizer Inc – Page 6

No Increased Stroke Risk Linked to Pfizer’s Covid Boosters, Federal Officials Say

An uptick hinted at in surveillance data was a mirage, the officials said.

By Apoorva Mandavilli

Beijing (China) BioNTech SE China Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Drugstores East Asia Hong Kong Hospitals Ibuprofen (Drug) Jinan (China) Pain-Relieving Drugs Paxlovid (Drug) Pfizer Inc Shanghai (China) Shortages

China’s Abrupt Covid Pivot Leaves Many Without Medicines

Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.

By David Pierson Isabelle Qian Olivia Wang and Tiffany May

Coronavirus (2019-nCoV) Coronavirus Omicron Variant Disease Rates Immune System Novavax Inc Pfizer Inc Research Vaccination and Immunization

Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.

The shots may help older, pregnant and immunocompromised Americans dodge serious illness or death. But the doses are not likely to prevent infections in any group, recent studies suggest.

By Apoorva Mandavilli

Children and Childhood GlaxoSmithKline PLC Infant Mortality Pfizer Inc Respiratory Diseases Respiratory Syncytial Virus (RSV) Vaccination and Immunization

Scientists Are Gaining On RSV, a Persistent Threat to Children

Vaccines and treatments are in trials, but the virus remains a leading killer of infants worldwide.

By Apoorva Mandavilli

mosaec